NCT04207801 - A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 21, 2020

Primary Completion Date

March 20, 2021

Study Completion Date

April 15, 2021

Conditions

Chronic Plaque-type Psoriasis

Interventions

DRUG

AUR101

Inhibitor of RORγ

DRUG

Matching Placebo

Drug-Placebo of AUR101 tablet

Trial Locations (9)

Apex Hospitals Private Limited, Jaipur

B.J Medical College & Civil Hospital, Ahmedabad

Sujata Birla Hospital & Medical Research Center, Nashik

Triveni Polyclinic, Nagpur

Shree Hospital and Critical Care Centre, Nagpur

NKP Salve Institute of Medical Sciences and Lata Mangeshkar Hospital, Nagpur

Kempegowda Institute of Medical Sciences, Bangalore

Sapthagiri Hospital, Bangalore

Life Line Diagnostic Centre Cum Nursing Home, Kolkata